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ABSTRACT: Joint injury causes post-traumatic osteoarthritis (PTOA). About 50% of patients rupturing their anterior cruciate ligament
(ACL) will develop PTOA within 1–2 decades of the injury, yet the mechanisms responsible for the development of PTOA after joint
injury are not well understood. In this study, we examined whole joint gene expression by RNA sequencing (RNAseq) at 1 day, 1-, 6-, and
12 weeks post injury, in a non-invasive tibial compression (TC) overload mouse model of PTOA that mimics ACL rupture in humans. We
identified 1446 genes differentially regulated between injured and contralateral joints. This includes known regulators of osteoarthritis
such as MMP3, FN1, and COMP, and several new genes including Suco, Sorcs2, and Medag. We also identified 18 long noncoding RNAs
that are differentially expressed in the injured joints. By comparing our data to gene expression data generated using the surgical
destabilization of the medial meniscus (DMM) PTOA model, we identified several common genes and shared mechanisms. Our study
highlights several differences between these two models and suggests that the TC model may be a more rapidly progressing model of
PTOA. This study provides the first account of gene expression changes associated with PTOA development and progression in a TC
model.  2016 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:474–485, 2017.
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Post-traumatic osteoarthritis (PTOA) is a painful and
debilitating disease that is caused by mechanical
destabilization of the joint and injury to the articular
cartilage; however, the molecular and cellular mecha-
nisms leading to cartilage degeneration due to trauma
are not well understood. It has been demonstrated
that inflammation,1 abnormal subchondral bone prop-
erties2 and loss of response to mechanical load3 all
contribute to the development of OA. Many individuals
developing OA are asymptomatic until significant joint
damage has occurred,4 at which point the only avail-
able long-term treatment options are surgical replace-
ment of the joint and/or pain management.5 Therefore,
identifying and characterizing OA biomarkers for
detecting and tracking the progression of the disease
combined with developing new pharmacologic inter-
ventions aimed to minimize cartilage damage trig-
gered by joint injury, are vital scientific endeavors.
In the past decade, using human biopsy and animal
OA models, new insights about joint OA pathogenesis
were uncovered. To date, several studies have evaluated
molecular changes associated with human arthritic joint
tissues including: Synovium,6 meniscus,7 cartilage,8,9
osteophytes,10 and subchondral bone.11 Many of these
studies revealed molecular changes associated with late
stages of OA but only a few examined earlier molecular
events because of clinical limitations. It is difficult to
discriminate asymptomatic OA tissues and compare
it to age matched healthy controls. Instead, mouse
models that mimic human OA have been used with
great success to study OA pathogenesis and to identify
putative molecular and genetic factors driving the
progression of the disease.12,13
Though OA is commonly diagnosed by visible
damage to the articular cartilage, more recent assess-
ments of OA have been migrating to evaluate the
entire joint, and perceive the disease as a multi
factorial, multi cell-type phenotype.14,15 In this study,
we used a non-invasive tibial compression (TC) mouse
model that closely mimics traumatic anterior cruciate
ligament (ACL) rupture in humans to study molecular
mechanisms driving PTOA development and progres-
sion.16 We hypothesized that a global gene expression
profiling of TC injured knee joints at early (1 day or
1 week post injury) and late (6 or 12 weeks post injury)
time points will unveil novel candidate genes and
molecular mechanisms responsible for PTOA develop-
ment and progression, and reveal new insights into
OA progression in TC model. Through RNA sequenc-
ing analysis (RNAseq) we identified 1446 differentially
regulated genes in injured joints, including several
long noncoding RNAs (lncRNAs) that have not been
previously studied in the context of PTOA. Further-
more, we compared our data with gene expression
data generated from the surgical destabilization of
the medial meniscus (DMM)17,18 model of PTOA, to
understand the commonalities and differences between
these two models.
MATERIALS AND METHODS
Animals and Tibial Compression (TC) Joint Injury
Wildtype C57B/L6 mice underwent injury by applying a TC
load (10–12N) to the right knee of 16 weeks old male mice,
as previously described.16 All animal experiments were
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conducted in accordance with institutional animal care and
use committee guidelines at Lawrence Livermore National
Laboratory and University of California, Davis.
Histology
Injured and uninjured (contralateral) joints were collected at
1 day, 1-, 6-, and 12 weeks (n¼ 5 per group) post injury.
Joints were dissected, fixed in 4% paraformaldehyde, decal-
cified using 0.5M EDTA, infiltrated in increasing concentra-
tions of isopropanol, equilibrated into mineral oil, and
embedded into paraffin wax. Six micrometer paraffin sections
were stained on glass slides using 0.1% Safranin-O and
0.05% Fast Green using standard procedures (IHC world)
and imaged using a Leica DM5000 microscope. Three blind
reviewers independently assessed OA severity using a modi-
fied OARSI19 scale to examine the medial compartment of
injured and uninjured joints (sagittal views) (grade scale 0–
0.5 normal; 1–2 mild; 3–4 moderate; 5–6 severe cartilage
damage).
Micro-Computed Tomography (micro-CT) Analysis and
Osteophyte Quantification
Quantification of epiphyseal trabecular bone of the distal
femur and osteophyte volume was carried out as previously
described.20 In brief, fixed joints were embedded into 1.5%
agarose to a desired angle and scanned with micro-computed
tomography (SCANCO micro-CT 35, Br€uttisellen, Switzerland).
Analysis was performed to quantify the microstructure of
trabecular bone of the distal femoral epiphysis and osteophyte
formation surrounding the joint. Joints were imaged under
the guidelines for micro-CT analysis for rodent bone structure
(X-ray tube potential¼ 55kVp, intensity¼ 114mA, 10mm
isotropic nominal voxel size, integration time¼ 900ms).21
Quantification of trabecular bone volume fraction (BV/TV),
trabecular number (Tb.N), trabecular thickness (Tb.Th), and
other microstructural parameters was done using the tools
provided by the manufacturer.16 Lastly, osteophyte volume
was calculated at terminal time points (6 and 12 weeks post
injury), and included all mineralized tissues in the joint space
except naturally ossified structures (patella, fabella, and
anterior/posterior horns of the menisci). Statistical analysis
was performed using a paired t-test to compare injured and
contralateral knees.
RNA Isolation and Sequencing (RNAseq)
Injured and contralateral joints (1 day [n¼ 5], 1- [n¼ 5],
6- [n¼ 3], and 12-weeks [n¼ 3]) were dissected and cut at the
base edges of femoral and tibial joint regions with small
traces of soft tissues to preserve the intact knee joint.
Dissected joints (between 0.25 and 0.3 g total weight) were
then cut into small pieces and submerged in RNA Later
(Qiagen) and stored at 4˚C until processing. RNA Later
solution was removed and dissected joints were homogenized
in Qiazol lysis solution (Qiagen); RNA was isolated utilizing
RNeasy Qiagen kits according to manufacturer’s instruc-
tions. Isolated RNA (between 1 and 2mg) was sequenced
using an Illumina HiSeq 2000.
RNAseq Data Analysis
RNAseq data quality was checked using “FastQC” (http://
www.bioinformatics.bbsrc.ac.uk/projects/fastqc). Sequence reads
were aligned to mouse genome (mm10) using “TopHat.”22
Differential gene expression analysis was conducted using
an FPKM (fragments per kilobase of transcript per million
mapped reads) based strategy and a count based strategy,
to reduce the number of false positive discoveries. In the
FPKM based strategy differentially expressed genes (DEGs)
were identified using “Cufflinks” and “Cuffdiff.”23 A gene was
considered significantly differentially expressed when its false
discovery rate (FDR) corrected p-value was < 0.05 and fold
change was greater than 1.5. Subsequently, DEGs were
filtered based on their expression values and low expressing
genes with FPKM value < 2 were removed. In the count based
strategy “featureCounts”24 was used to perform read summa-
rization on reads mapped with “TopHat.” Subsequently, the
data was normalized using “voom”25 and DEGs with fold
change > 1.5 and p-value < 0.05 were identified using
“limma.”26 Genes identified by both methods as significantly
differentially expressed were used to generate a list of high-
confidence DEGs. These high-confidence DEGs were used for
further analyses. Venn diagrams were created using R package
“VennDiagram.” Heatmap was generated using heatmap.2
function in R package “gplots.”
Microarray Data Analysis
Previously published microarray data were downloaded from
Gene Expression Omnibus (GEO) and the data analysis was
conducted using Bioconductor.27 Affymetrix data7,10,28 pre-
processing and normalization were performed using RMA
method.29 Agilent data17 were background corrected with
Normexp, normalized within arrays with loess and between
arrays with Aquantile.26 Differentially expressed genes were
identified using “limma.”26 Genes with p-value < 0.05, FDR
corrected p-value < 0.1 and fold change > 1.5 were considered
significantly differentially expressed.
Functional Annotation
Gene ontology analysis was performed using DAVID30 and
enriched gene ontology terms (p-value < 0.01) were identified.
Long noncoding RNA (lncRNA) gene annotations were
obtained from GENCODE.31 ToppCluster was used to cluster
differentially expressed genes from different time points based
on phenotype enrichment32 and Cytoscape was used for
cluster visualization.33 Mouse phenotype data was obtained
from MGI database (http://www.informatics.jax.org/).
RESULTS
Molecular Changes Associated With PTOA Development
Knee injury was induced by applying a single compres-
sive load (10–12N) to the right knee (Fig. 1A), as
previously described.16,34 Injured and contralateral
joints were examined histologically and by RNAseq
at 1 day, 1-, 6-, and 12 weeks post injury (Fig. 1B).
Contralateral controls revealed minimal pathological
changes at all times examined (Fig. 1C). Furthermore,
no obvious morphological changes were observed histo-
logically at 1 day post injury (Fig. 1D), suggesting that
no articular fracture or damage was initially intro-
duced by the compressive load and knee dislocation.
As previously reported, we observed severe cartilage
erosion (Fig. 1E and F) with osteophyte formation
(Fig. 1G–I) at 6- and 12 weeks post injury.16,34
Significant subchondral bone loss was also observed at
6- and 12 weeks post injury (Fig. 1J).
The FPKM and the count based methods (Fig. 2A)
jointly identified a total of 1446 DEGs (Suppl.
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Table S1), where 599, 644, 511, and 201 DEGs were
found at 1 day, 1-, 6-, and 12 weeks post injury,
respectively (Fig. 2B and C). At 1 day, several genes
up/down-regulated in injured joints in response to
injury were also found to be up/down-regulated in
contralateral joints compared to age matched WT
controls. However, by 1 week post injury the expres-
sion of many of the genes reverted back to WT control
levels (Suppl. Fig. S1). The largest overlap among the
DEGs was found between 1 day and 1 week post
injury, where 272 up- and 23 down-regulated genes
were in common (Fig. 2B and C). We also identified
15 genes that were up-regulated at all time points
examined (Table 1). Interestingly, no genes were found
to be down-regulated at all time points. Genes up-
regulated at all time points included extracellular
matrix (ECM) components (Fn1,9 collagens 3, 5, and
6,35,36 Cthrc1, Thbs3), matrix metabolic enzymes
(Mmp337) and Wnt signaling proteins (Sfrp2 and
Wisp2). In addition, it included ECM and cell adhesion
proteins (SRPX2 and TNN) and a synovial fibroblast
cell surface marker38 (THY1). We also identified 18
lncRNAs including Dnm3os, Rian, H19, and Snhg18
differentially regulated in injured knee joints com-
pared to uninjured controls (Table 2).
Gene Ontology Analysis of Differentially Regulated Genes
For up-regulated genes, gene ontology categories cor-
responding to vasculature development, cell adhesion,
extracellular matrix organization, extracellular struc-
ture organization, and collagen fibril organization
were enriched at all time points examined (Table 3).
Categories corresponding to regulation of cell prolifer-
ation and chondroitin sulfate proteoglycan metabolic
process were enriched at all but the 12 week time
point. Angiogenesis and hypoxia genes were enriched
only at 1 day and 1 week post injury, while categories
covering bone and cartilage development and collagen
catabolism were enriched only at 1- and 6 weeks post
injury correlating with the emergence of osteophyte
formation and cartilage degradation as observed by
histological analysis and micro-CT (Fig. 1E and F).
Wnt signaling was enriched only at 1 week, while
genes associated with cell cycle were enriched at
6 weeks post injury. Categories corresponding to
immune responses were enriched at 1 day, 6- and
Figure 1. Histological evaluations of tibial com-
pression (TC) OA injury. (A) TC overload leads to
joint destabilization though ACL dislocation. The
direction of joint displacement is indicated by the
red arrow. (B) Time line where mice were injured
and joints were collected at 1 day, 1-, 6-, and
12 weeks for either histology or RNA sequencing.
Histological assessment of uninjured (C) and
injured joints at various time points post injury
(D–F) by Safranin-O and Fast Green staining.
Micro-CT highlight regions (dark gray) of osteo-
phyte formation in 6- (G) and 12- (H) weeks
injured joints. (I) Micro-CT quantification of
osteophyte formation in injured joints. (J) Quan-
tification of femoral subchondral trabecular
bone formation between injured and uninjured
joints. All histological images were presents were
taken at 10 magnification. Scale bar is 1mm;
 p< 0.01.
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12 weeks post injury, while markers of inflammation
were enriched at 1 day and 12 weeks post injury.
Inflammation related genes up-regulated at 12 weeks
post injury include several complement pathway com-
ponents such as C1qa, C1qc, Cfb, and Cfp. These data
suggest that significant cartilage remodeling occurs
shortly after injury, while immune responses oscillate,
with an early phase at 1 day and a later phase
initiating at 6 weeks post injury.
For down-regulated genes monosaccharide meta-
bolic process and alcohol catabolic process were
enriched at all but the 12 weeks post injury time point.
Categories corresponding to glycolysis, generation
of precursor metabolites and energy, and striated
muscle tissue development were enriched at 1 week
Table 1. Transcripts That Were Up-Regulated in Injured
Joints, at All Time Points Examined
No. Gene Name 1 Day 1 Week 6 Weeks 12 Weeks
1 Mmp3 4.46 5.68 11.74 6.14
2 Col3a1 4.10 5.74 4.05 3.93
3 Cthrc1 3.83 5.05 1.86 2.92
4 Sfrp2 3.41 4.61 3.18 3.03
5 Wisp2 3.08 2.67 1.81 2.67
6 Tnn 2.69 4.22 3.17 3.02
7 Col5a1 2.52 3.80 2.43 2.17
8 Col6a3 2.24 4.39 3.14 2.39
9 Srpx2 2.21 2.94 2.53 2.48
10 Thy1 2.11 2.50 2.18 2.52
11 Col6a2 2.10 4.31 2.41 2.81
12 Col6a1 2.07 4.17 2.29 2.44
13 Col5a2 2.05 2.89 2.70 2.65
14 Thbs3 1.80 3.95 4.10 2.50
15 Fn1 1.58 3.02 4.46 2.93
Values represent the fold changes between injured and uninjured
joints (p<0.05).
Table 2. Long Noncoding RNAs Differentially Expressed
in Injured Joints
No. LncRNA Name 1 Day
1
Week
6
Weeks
12
Weeks
1 Dnm3osa 0.672 1.324 ns ns
2 Rian 0.942 2.002 ns ns
3 2810433D01Rik 1.022 ns ns ns
4 H19b ns 0.98 ns ns
5 Snhg18 ns 0.777 ns 1.028
6 2610203C20Rik ns 0.892 ns ns
7 Gm11974 ns ns 1.706 ns
8 E330020D12Rik ns ns 1.807 ns
9 AI504432 ns ns 0.942 ns
10 Tmem134 ns ns ns 0.981
11 2310065F04Rik 1.044 ns ns ns
12 C130080G10Rik 2.921 ns ns ns
13 1810044D09Rik ns 1.007 ns ns
14 Plet1os ns 0.988 ns ns
15 2610306M01Rik ns ns 0.616 ns
16 0610040B10Rik ns ns 1.647 ns
17 BC018473 ns ns 1.04 ns
18 2610035D17Rik ns ns 0.87 ns
alncRNAs previously shown to function during skeletal develop-
ment; bor be dysregulated in OA cartilage. Values represent the
log2 fold changes between injured and uninjured joints (p<0.05)
Figure 2. RNA sequencing analysis methodo-
logy and differentially expressed transcripts. (A)
Flowchart of RNAseq data analysis. All of the
differentially regulated genes presented were
identified by both the FPKM based method and
the count based method as significantly differen-
tially expressed (p<0.05). Common differentially
up (B) and down (C) regulated genes between
every time point post TC injury. The total number
of genes per category is in brackets beneath each
time point.
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and 6 weeks post injury. Genes associated with nega-
tive regulation of osteoblast differentiation, and carbo-
hydrate and lipid biosynthetic processes were enriched
at 1 day, while muscle organ development, muscle
system process, and response to heat were enriched at
1 week post injury. Categories corresponding to ATP
metabolic process, oxidative phosphorylation, and elec-
tron transport chain were enriched at 6 weeks post
injury. We found several components of mitochondrial
electron transport chain including Ndufa1, Ndufa2,
Ndufb3, and Uqcr10 to be down-regulated at 6 weeks
post injury suggesting aberrant mitochondrial activity.
The 12 week time point did not reveal enrichment for
any ontology categories.
Phenotype Enrichment Analysis
We performed a comparative phenotype enrichment
analysis using ToppCluster32 and identified enriched
mouse phenotypes associated with the DEGs. For
up-regulated genes, inflammatory/immune response
related phenotypes and muscle phenotypes were
found to be enriched at 1 day post injury, whereas
both 1- and 6 weeks data showed enrichment for
cartilage and bone phenotypes. Three categories:
Arthritis, abnormal cutaneous collagen fibril morphol-
ogy, and abnormal tendon morphology were enriched
at all time points, except 12 weeks post injury. We
identified 26 genes with arthritis phenotypes up-
regulated at 1 day, 1- and/or 6 weeks (Fig. 3).
While 1 day, 1- and 6 weeks data shared a signifi-
cant overlap, the 12 weeks post injury data did not
have any overlap with any other time points, and
showed enrichment for only two categories: Abnormal
response to infection and increased susceptibility to
infection, suggesting that the severe cartilage damage
observed histologically at this point (Fig. 1F) may
render the organism susceptible to secondary health
consequences due to viral or bacterial exposure
(Fig. 3). Genes down regulated at 1- and 6 weeks
showed enrichment for muscle phenotypes; by con-
trast, 1 day and 12 weeks genes did not show enrich-
ment for any mouse phenotypes. Genes associated
with abnormal glycogen and triglyceride levels were
also found to be enriched at 1 week post injury. These
Figure 3. Enriched phenotypes associated with genes up-regulated at 1 day (D1), 1- (W1), 6- (W6), and 12 weeks (W12) post injury.
Up-regulated genes associated with Arthritis phenotypes are highlighted at the bottom, left side.
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data suggest that at early stages post injury, inflam-
mation, and vasculature are in play with the attempt
to repair and remodel both cartilage and bone. How-
ever at later stages post injury, the enrichment in
abnormal bone and cartilage morphology categories
are consistent with a damaged joint that has accrued
significant morphological changes in bone and carti-
lage such as articular cartilage erosion and osteophyte
formation, which are consistent with the histological
and micro-CT evaluations (Fig. 1E–J).
Comparison With Gene Expression Changes Induced by
DMM Surgery
DMM is a widely used and validated animal model for
studying PTOA.13 Gene expression profiling have been
recently conducted on DMM injured mouse knee joints,
and significant transcriptional changes were reported
at 2-, 4-, and 16 weeks time points for whole-joint
derived RNA28 and at 1-, 2-, and 6 weeks time points
for micro-dissected articular cartilage derived RNA.17
We compared TC gene expression data to DMM
model17,28 to determine the commonalities and differ-
ences between TC induced and DMM induced PTOA, at
the molecular level. 485 (whole joint; 472 up- and 13
down-regulated) and 189 (micro-dissected cartilage; 168
up- and 21 down-regulated) of the DMM differentially
expressed transcripts overlapped with our TC data,
at least at one time point examined. A full list of
these overlapping genes is provided in Supplementary
Table S1. For significantly up-regulated genes in whole
joint RNA, 1 week post-TC and 4 weeks post-DMM
injury had the largest overlap, with 382 shared (74.32%
of TC genes) differentially expressed genes, while only
228 transcripts overlapped between the 1 week post-TC
and 2 weeks post-DMM (whole joint). When micro-
dissected DMM cartilage was compared to our data,
1 week post-TC and 2 weeks post DMM (cartilage) had
the largest overlap, with 139 shared genes (27% of TC
genes) (Table 4). Only 67 transcripts overlapped be-
tween the 1-week post-TC and 1-week post-DMM
(cartilage). The 6 weeks TC data shared only 32 genes
with the 6 weeks cartilage data but had a 125 gene
overlap with the 4 weeks DMM whole joint data.
Very few genes were found to overlap among the
differentially down-regulated transcripts or between
our 12 weeks and the whole joint DMM 16 week data
(Table 4).
TC model uniquely identified 582 up-, 295 down-,
and 15-mixed (up or down at different time points)
regulated genes (Suppl. Table S1). This includes several
immune/inflammatory response related genes such as
Ccr2, C1qa, C1qb, C1qc, and Cfb; bone development
related genes such as Spp1, Ctgf, Dmp1, Gabbr1, and
Pth1r; cell adhesion genes such as Emilin1, Gpnmb,
Itga5, and Stab1 and energy metabolism genes such as
Ndufa1, Ndufa2, Ndufb3, Uqcr10, and Sdhb.
DISCUSSION
The TC induced ACL rupture model of PTOA is a
new animal model that has not yet been widely
Table 4. Gene Expression Similarities Between TC (Tibial Compression) and DMM (Destabilization of Medial
Meniscus) at Various Time Points Post Injury
Time Point
TC
1 Day (496) 1 Week (514) 6 Weeks (370) 12 Weeks (174)
No. Genes % Genes No. Genes % Genes No. Genes % Genes No. Genes % Genes
DMM up-regulated transcripts
1 week (C) n/c 67 13.04 n/c n/c
2 weeks (C) n/c 139 27.04 n/c n/c
2 weeks (WJ) 168 33.87 228 44.36 68 18.38 26 14.94
4 weeks (WJ) 262 52.82 382 74.32 125 33.78 36 20.69
6 weeks (C) n/c n/c 32 8.65 n/c
16 weeks (WJ) 21 4.23 41 7.98 28 7.57 14 8.05
1 Day (103) 1 Week (130) 6 Weeks (141) 12 Weeks (27)
No. Genes % Genes No. Genes % Genes No. Genes % Genes No. Genes % Genes
DMM down-regulated transcripts
1 week (C) n/c 4 3.08 n/c n/c
2 weeks (C) n/c 17 13.08 n/c n/c
2 weeks (WJ) 5 4.85 6 4.62 1 0.71 0 0.00
4 weeks (WJ) 9 8.74 6 4.62 1 0.71 0 0.00
6 weeks (C) n/c n/c 4 2.84 n/c
16 weeks (WJ) 0 0.00 0 0.00 0 0.00 0 0.00
C, cartilage (Bateman et al.)17; WJ, whole joint (Loeser et al.)18; n/c comparison was not conducted. Number of overlapping genes are
presented as the net number of genes up- (a) or down- (b) regulated in both the TC and DMM datasets, as well as percentage of the
entire gene expression data set described for the TC time points.
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explored to study mechanisms of joint OA develop-
ment. This study provides the first account of whole
genome expression profiles to obtain new insights
into the temporal progression of the disease in the
TC PTOA model. Despite being a noninvasive proce-
dure, and exhibiting no obvious morphological or
structural damages to tissues other than the ACL
(Fig. 1C), we observed the largest transcriptional
changes at early time points, with 599 and 644
transcripts being differentially expressed, at 1 day
and 1 week post injury, respectively. Also, most of
the differentially expressed genes were up-regulated,
with less than 30% of differentially expressed genes
being significantly down-regulated, at any time point
examined.
Consistent with reports by Gardiner et al.9 where
they examined transcriptional changes in micro-dissected
cartilage derived from DMM injured joints, we also
identified Tnn (tenasinN) and Fn1 (fibronectin 1) as
two transcripts consistently up-regulated at all time
points examined (Table 1). Also, similar to previous
reports on DMM gene expression time-course experi-
ments,9,28 the TC model of PTOA also undergoes a
decline in transcriptional changes with time, where by
12 weeks post injury, only 201 transcripts are differen-
tially expressed, suggesting that the joint adapts to
the injury, with time, to reach a new molecular
homeostasis, despite the enormous articular cartilage
loss evident at this time point (Fig. 1F).
In addition, our model captures many of the tran-
scriptional changes previously reported for DMM
damaged cartilage, both reported for whole joints and
micro-dissected cartilage. We identified several genes
including Mmp3, Errfi1, and C1qtnf3 with known
arthritis phenotype as differentially regulated in TC
data and both DMM datasets. C1qtnf3 has previously
been implicated in autoimmune arthritis39; however,
further studies are required to understand its role in
OA. We also identified several regulators of Wnt
signaling including Sfrp1, Sfrp2, Sfrp4, Dkk2, and
Dkk3 and TGFb signaling including Ltbp1, Fbn1, and
Fbn2 commonly changed in both the TC and DMM
models. Our 1 week data has the largest overlap with
the 4 weeks post injury DMM28 whole joint data,
where 74% of our up-regulated transcripts were also
found transcriptionally elevated in the DMM injured
joints. We also found significant overlap between our
1 week post injury data and DMM injury pure
cartilage data, where 67 up-regulated genes (13%)
overlapped with the 1 week and 139 up-regulated
genes (27%) overlapped with 2 weeks post DMM injury
(Table 4). These data provides confirmation that the
TC model recapitulates a large proportion of the gene
expression reported for the DMM model, both at
the whole joint and at the pure cartilage level.
However these data also shows that these molecular
changes happened at a faster rate in the TC model,
suggesting that the TC injury may be a rapidly
progressing PTOA model than DMM.
We also compared our data to previously published
expression data of different human OA tissues including
synovium,6 osteophyte,10 tibial plateau,11 articular
cartilage,8,40 and meniscus7 and found that majority
of genes commonly differentially regulated between
both human OA and TC induced mouse OA correspond
to osteophyte and subchondral bone changes (Suppl.
Table S2), consistent with osteophyte formation
being a major hallmark of PTOA in humans and
recapitulated in the TC mouse model examined here
(Fig. 1G and H).
Interestingly, few genes up-regulated in the TC
PTOA time course are found to be significantly up-
regulated in the patient-derived OA cartilage. In
particular one gene, Col6A2 is up-regulated in TC
joints, at all times points examined, but significantly
up-regulated in human OA articular cartilage only.
Mutations in this protein are primarily associated
with myopathies,41 but may also have an important
role in ECM remodeling in PTOA. Serpines are pepti-
dase inhibitors and Serpine2 has been shown to
up-regulated in cultured chondrocytes in response to
IL-1a to inhibit MMP13 expression. We find Serpine1
to be significantly up-regulated at 1 day and 1 week
post injury, and similarly this molecule is up-regulated
in OA articular cartilage, suggesting that the upregu-
lation of this peptidase may represent a regulatory
mechanism for repressing the expression of cartilage
catabolic enzymes.
Several genes identified in our study including
Fndc1, Fads3, Edil3, C1qtnf6, Il1r1, Ptgs2, Rel, Tlr4,
and Aldh1a2 were previously identified by genome
wide association studies (GWAS) as potential OA,
rheumatoid arthritis (RA), or ankylosing spondylitis
(AS) susceptibility loci. These genes commonly altered
in both PTOA and other degenerative joint diseases
may highlight molecular components of potentially
shared mechanisms that contribute to joint degenera-
tion.
Our study also allowed us to examine transcrip-
tional changes in several lncRNAs. We identified 18
lncRNAs differentially transcribed at least at one time
point, 10 that were up- and 8 that were down-
regulated (Table 2). Two of these lncRNAs, Dnm3os,
and H19 have been previously described in the context
of skeletal development42 or OA,43 but all other
lncRNAs identified herein have yet to be studied in
the context of PTOA development. Furthermore, since
we do not observe broad activation or repression across
all time points examined, but rather see groups of
lncRNAs transcriptionally changed at single time
points, we speculated these noncoding RNAs may
have unique functions to modulate the transcription
of “function specific” cohorts of genes. Also, it would
be interesting to determine whether some of these
lncRNAs are modulated by the immune system, since
initial changes in inflammation may be able to trigger
large cascades of gene expression by repressing or
activating these regulatory RNAs.
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A list of possible genes that remain to be explored
as candidate biomarkers or local joint therapeutics
includes Ssc5d, a gene primarily expressed in mono-
cytes/macrophages and T-lymphocytes44 and Cemip
(KIAA1199), a gene involved in hyaluronan (HA)
metabolism.45 SSC5D, a soluble scavenger protein,
was previously identified to be elevated in synovial
fluid of OA patients.46 HA plays an important role in
maintaining the integrity of articular cartilage by
providing lubrication between the femoral and tibial
surfaces. Cemip (KIAA1199) is a gene that enhances
HA catabolism in the synovium45 and improves growth
and angiogenesis of synovial tissue.47 However its role
in OA developing joints has not yet been explored and
inhibitors of Cemip may potentially prevent cartilage
degradation post injury.
Our study also identified several novel genes includ-
ing Suco, Sorcs2, and Medag. Suco (Opt) encodes
a widely expressed rough endoplasmic reticulum-
localized integral membrane protein. Mice lacking
Suco develop acute onset of skeletal defects including
impaired bone formation and spontaneous fractures.48
Suco is >2-fold up-regulated at 6 weeks post injury
suggesting a role in aberrant bone remodeling
and/or osteophyte formation. Sorcs2 is a member of
vacuolar protein sorting 10 family proteins
(VPS10Ps) with a potential role in protein trafficking
and cell signaling.48 Recent GWAS study identified
Sorcs2 as a candidate loci associated with cranial
cruciate ligament rupture in Newfoundland dogs,49
however this gene has not been previously studied in
the context of osteoarthritis. Medag, a gene we found
up-regulated at 1 day, 1- and 6 weeks has been
shown to play a role in adipose tissue development50;
however, its role in osteoarthritis has yet to be
explored.
There are a few potential limitations to our study.
First, we utilized the contralateral joint as controls
instead of age matched sham injured joints. Because of
this, it is difficult to distinguish between changes
mediate by the injury that had systemic effects on
both joints. In addition, there may also be changes
occurring in the contralateral as a result of altered
loading (more use of one joint) and changes in the
injured joint/leg due to reduced mobility, disuse and
pain. Second, because we are sequencing whole joints
instead of individual tissues of the joint, to tease out
where the gene expressions are coming from presents
a challenge. However, because OA is considered a
“joint disease,” comprehensive intact joint analysis
may allow us to identified changes in tissues that may
not normally be assumed to contribute to cartilage
degradation or remodeling, such as muscle. Because of
these caveats, we may lose some genes that are
differentially expressed in a small area, or genes that
are normally expressed broadly, but are affected
regionally. These challenges may be overcome by
examining candidate proteins for their tissue specific
expression.
Our study uniquely introduces the gene expression
changes associated with a new, noninvasive model
of PTOA.34 This model closely mimics human ACL
injuries resulted from a single high impact damage
that leads to PTOA development. Our data provides
evidence that a significant number of changes in
the TC model correlate with both whole joint derived
RNA and micro-dissected cartilage derived RNA
from the DMM model. Our study also highlights the
differences between two models at the molecular
level where our earlier time points (1 week) revealed
more similarities with the later DMM time points
(4 weeks), suggesting that TC model may be a more
rapidly progressing PTOA model. Therefore, the
TC model may be more suitable for investigating
rapidly progressing joint failure and events occurring
at earlier stages of traumatic injury. The pathways
and candidate genes presented herein represent
additional opportunities for investigating new poten-
tial therapeutic targets and susceptibility loci for
PTOA.
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